Home950210 • KRX
add
Prestige Biopharma Ltd
Previous close
₩18,670.00
Day range
₩18,160.00 - ₩19,290.00
Year range
₩9,130.00 - ₩20,900.00
Market cap
1.14T KRW
Avg Volume
307.18K
Market news
Financials
Income Statement
Revenue
Net income
(KRW) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 3.34B | 422.99% |
Operating expense | 18.69B | 7.50% |
Net income | 50.46B | 3,609.50% |
Net profit margin | 1.51K | 771.05% |
Earnings per share | — | — |
EBITDA | -11.28B | 18.45% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
(KRW) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 213.27B | -15.56% |
Total assets | 793.96B | 11.73% |
Total liabilities | 252.88B | 30.07% |
Total equity | 541.08B | — |
Shares outstanding | 300.48M | — |
Price to book | 12.67 | — |
Return on assets | -4.95% | — |
Return on capital | -5.65% | — |
Cash Flow
Net change in cash
(KRW) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 50.46B | 3,609.50% |
Cash from operations | -3.30B | 69.66% |
Cash from investing | -22.37B | -267.17% |
Cash from financing | 589.70M | 414.37% |
Net change in cash | -18.62B | 1.47% |
Free cash flow | -16.56B | 0.59% |
About
Founded
2015
Website
Employees
66